Social Media Ideas for Precision Oncology

Patient-Derived Tumor Organoids Show Promise for Personalizing Cancer Treatment

Researchers developed a 220-sample pan-cancer patient-derived organoid platform that faithfully mirrors tumors, identifies new treatment opportunities, and advances precision oncol...

Tumor Profiling Reveals Chemotherapy Effects and Personalized Treatments for Ovarian Cancer

A groundbreaking study published in Nature Communications unveils a comprehensive tumor profiling resource that promises to revolutionize the treatment landscape for ovarian cancer...

OncoLens' AI-Powered Analytics Platform Helps Large Academic Cancer Center in Florida Cut Referral Delays and Surface Ca...

Case study finds nearly 9 in 10 actionable cancer data points existed only in unstructured text invisible to standard EMR reporting; OncoLens Analytics helped the center lift on-ti...

<![CDATA[BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies ]]>

OpenEvidence deepens oncology push to build specialized AI agents, launches new AI model family

The partnership builds on OpenEvidence's vision to develop “medical super-intelligence” based on agentic artificial intelligence, or a system of AI agents that can be subspecialist...

Natera teams with Angiex on cancer drug trial monitoring

Natera inked a collaboration deal with biotech Angiex to assess the use of its Signatera blood test, which looks for small traces of cancer DNA in patients who have been diagnosed...

RNA-based testing uncovers extraordinary diversity in mutations driving lung cancer

RNA sequencing improved detection of clinically important MET exon 14 skipping events, helping identify lung cancer patients who may benefit from targeted therapies...

AI Advances Revolutionize Oncology Drug Discovery from Targets to Therapies

Artificial Intelligence Revolutionizes Cancer Drug Discovery, Paving the Way for Next-Generation Therapies The arduous journey of developing effective cancer drugs, marked by high...

4baseCare launches TARGT Indiegene® V2, bringing a biology-first approach to comprehensive cancer profiling

Five years after the launch of Indiegene V1, the next generation expands to 2,206 genes with most comprehensive coverage of Hallmarks of Cancer, HRD… The post 4baseCare launches TA...

Locking therapeutic strategy could make cancer treatment more precise

Although modern cancer treatments can eliminate malignant cells with remarkable efficiency, their lack of perfect selectivity often exposes healthy tissues to the same molecular as...

SA Asks: What are the most promising oncology companies right now?

Genetic medicine luminaries launch new center for personalized therapies

A team of veteran scientists from elite institutions has come together to form a new center dedicated to the crafting of personalized genetic medicines, adding to the growing list...

Not Yet AI Curing Cancer But Validating Gains Can Be Made

The Moderna Neoantigen selection. A tumor carries thousands of mutations. Only a handful produce peptides that get presented on MHC and recognized by T cells. Moderna’s pipeline ta...

How East Ocyon Bio is building an off-the-shelf cancer cell therapy in Gurugram

The Gurugram-based company is developing allogeneic CAR-NK cell therapies made from healthy donor cells, backed by a $4.2 million seed round and a government grant covering both re...

AcademyHealth Releases Strategic Roadmap for Advancing Cancer Biomarker Testing at Scale

AcademyHealth Releases Strategic Roadmap for Advancing Cancer Biomarker Testing at Scale For patients facing uncertainty or fear around a cancer diagnosis, cancer biomarker...

ALFAssay: A feed‑forward neural network for quantitative fragmentomics‑based ctDNA profiling in breast cancer

by Alexandra Stanciu, Andrea Gombos, Elisa Agostinetto, Delphine Vincent, Laurence Buisseret, Andreas Papagiannis, Francoise Rothe, Nicola Occelli, Christos Sotiriou, David Venet,...

Novel AI model trained on RNA-Seq data accurately detects key gene mutations and predicts biomarkers across 32 cancer ty...

RNA sequencing and pathology imaging data helped train an AI model to predict TP53 mutations, gene expression, cancer type, and clinical outcomes across solid tumors...

Genentech doubles down on ADC-resistant cancers with $1B DualityBio pact

Roche’s Genentech is paying DualityBio $45 million upfront for rights to antibody-drug conjugates (ADCs) designed for the growing pool of patients who progress after treatment with...

An alignment-free strategy for circulating tumor DNA detection and tumor fraction estimation from whole-genome sequencin...

by Carmen Oroperv, Amanda Frydendahl, Tenna Vesterman Henriksen, Giovanni Santacatterina, Alice Antonello, Nicola Calonaci, Mads Heilskov Rasmussen, Giulio Caravagna, Claus Lindbje...

Imagene AI and Tel Aviv Sourasky University Medical Center (Ichilov) Build Clinical AI Infrastructure to Advance Precisi...

The collaboration will enable the development, validation, and application of advanced AI technologies to identify clinically meaningful patient subgroups, support biomarker-driven...

Priority Health Launches 2 Cancer Support Solutions with Color Health, Grail

Priority Health partnered with Color Health and Grail to offer self-funded employers virtual cancer navigation, support and multi-cancer early detection beginning in 2027. The post...

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer

The Phase I dose escalation trial of ACESOT-1051 (NCT06260514) will accelerate its patient enrollment, with Aprea planning to more than triple its number of active clinical sites f...

McKesson strikes $2.25B deal to snap up Precision Medicine Group

The healthcare conglomerate, which ranks eighth on the Fortune 500 list, is set to envelop privately held Precision Medicine Group into its oncology branch as part of an ongoing ef...

Labcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseases

Labcorp is launching the Marker by Labcorp Genetic Health Panel, a new direct-to-consumer genetic testing tool that analyzes 163 genes to determine patients’ risk of over 100 hered...